 |
 Video: What is a Stock Split?
|
|
|
| PMV Pharmaceuticals is a precision oncology company focusing on the discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 is a tumor suppressor protein known as the guardian of the genome, and normal, or wild-type, p53 has the ability to eliminate cancer cells. Co.'s main product candidate, PC14586, is an orally available small molecule designed to correct p53 misfolding caused by a specific p53 mutation, Y220C, while sparing wild-type p53. PC14586 is designed to restore the wild-type conformation by occupying the crevice created by the tyrosine to cysteine mutation in amino acid position 220. According to our PMV Pharmaceuticals stock split history records, PMV Pharmaceuticals has had 0 splits. | |
|
PMV Pharmaceuticals (PMVP) has 0 splits in our PMV Pharmaceuticals stock split history database.
Looking at the PMV Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PMV Pharmaceuticals shares, starting with a $10,000 purchase of PMVP, presented on a split-history-adjusted basis factoring in the complete PMV Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/28/2020 |
|
| End date: |
04/23/2024 |
|
| Start price/share: |
$36.19 |
|
| End price/share: |
$1.81 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-95.01% |
|
| Average Annual Total Return: |
-56.82% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$498.89 |
|
| Years: |
3.57 |
|
|
|
|
|
